Assertio Holdings, Inc. Appoints Mark Reisenauer to Its Board of Directors
17 déc. 2024 08h30 HE
|
Assertio Holdings, Inc.
LAKE FOREST, Ill., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities...
Assertio Holdings, Inc. Appoints Paul Schwichtenberg to New CTO Role, Mary Pietryga as CCO
12 déc. 2024 08h00 HE
|
Assertio Holdings, Inc.
LAKE FOREST, Ill., Dec. 12, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities...
Assertio Reports Third Quarter 2024 Financial Results
11 nov. 2024 16h02 HE
|
Assertio Holdings, Inc.
Third Quarter Total Net Product Sales of $28.7 Million Rolvedon Net Product Sales of $15.0 Million Cash and Short-Term Investments of $88.6 Million LAKE FOREST, Ill., Nov. 11, 2024 ...
Assertio Provides Response to Letter from Short-seller
11 nov. 2024 07h30 HE
|
Assertio Holdings, Inc.
Claims about Rolvedon and Assertio’s Accounting Practices are False and Baseless Short-seller’s Press Release is Another Improper Attempt to Enrich Himself at Assertio’s Expense Company Considering...
Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
04 oct. 2024 16h05 HE
|
Assertio Holdings, Inc.
LAKE FOREST, Ill., Oct. 04, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT), a pharmaceutical company with comprehensive commercial capabilities...
Assertio Reports Second Quarter 2024 Financial Results
07 août 2024 16h01 HE
|
Assertio Holdings, Inc.
Assertio Reports Second Quarter 2024 Financial Results
Assertio Holdings, Inc. to Report Second Quarter 2024 Financial Results on August 7, 2024
24 juil. 2024 16h05 HE
|
Assertio Holdings, Inc.
LAKE FOREST, Ill., July 24, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities...
Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
09 juil. 2024 16h30 HE
|
Assertio Holdings, Inc.
LAKE FOREST, Ill., July 09, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT), a pharmaceutical company with comprehensive commercial capabilities...
ASSERTIO ALERT: Bragar Eagel & Squire, P.C. is Investigating Assertio Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
03 juil. 2024 22h00 HE
|
Bragar Eagel & Squire
NEW YORK, July 03, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Assertio Holdings, Inc....
Assertio Announces the Appointment of Brendan P. O’Grady as New CEO
29 mai 2024 07h00 HE
|
Assertio Holdings, Inc.
Assertio appoints Brendan P. O'Grady as CEO